Gastric Motility Disorder – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 40
Inquire Before Buying

Gastric Motility Disorder – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Gastric Motility Disorder – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Gastric Motility Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Motility Disorder. Gastric Motility Disorder – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gastric Motility Disorder.
- A review of the Gastric Motility Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Gastric Motility Disorder pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Gastric Motility Disorder.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Gastric Motility Disorder pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Gastric Motility Disorder – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gastric Motility Disorder Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Gastric Motility Disorder 7
Gastric Motility Disorder Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Gastric Motility Disorder Therapeutics - Products under Development by Companies 14
Companies Involved in Gastric Motility Disorder Therapeutics Development 15
Theravance, Inc. 15
Helsinn Healthcare S.A. 16
Tranzyme Pharma, Inc. 17
Concert Pharmaceuticals, Inc. 18
Elixir Pharmaceuticals, Inc. 19
Gastric Motility Disorder - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
ulimorelin hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TZP-102 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
EX-1314 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
velusetrag - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ipamorelin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
TD-8954 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34
Gastric Motility Disorder - Product Development Milestones 38
Featured News & Press Releases 38
Jun 06, 2012: Tranzyme To Present Data On TZP-102 At American Diabetes Association Scientific Sessions 38
Jun 01, 2012: RaQualia Pharma Initiates First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Feb 29, 2012: RaQualia Pharma Receives MHRA Approval To Initiate First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40

List of Tables
Number of Products Under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Comparative Analysis by Late Stage Development, H2 2012 10
Comparative Analysis by Mid Clinical Stage Development, H2 2012 11
Comparative Analysis by Early Clinical Stage Development, H2 2012 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Theravance, Inc., H2 2012 15
Helsinn Healthcare S.A., H2 2012 16
Tranzyme Pharma, Inc., H2 2012 17
Concert Pharmaceuticals, Inc., H2 2012 18
Elixir Pharmaceuticals, Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34

List of Figures
Number of Products under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Late Stage Products, H2 2012 10
Mid Clinical Stage Products, H2 2012 11
Early Clinical Stage Products, H2 2012 12
Pre-Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Global Aramid Fiber Industry to Witness High Growth in the Future
    With increasing use of aramid fibers in various industries, the global market for aramid fibers has grown significantly in recent years. Aramid fibers have a number of properties such as low density, heat resistance, high tensile strength, abrasion resistance, chemical resistance and impact resistance.  Asia-Pacific is the largest market for aramid fibers, followed by North [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Adenocarcinoma of the Gastroesophageal Junction – Pipeline Review, H2 2014
    Published: 30-Nov-2014        Price: US $2000 Onwards        Pages: 146
    Global Markets Direct's, ‘Adenocarcinoma Of The Gastroesophageal Junction Pipeline Review, H2 2014', provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Adenocarcinoma Of The Gastroesophageal Junction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ......
  • Global Irritable Bowel Syndrome Market 2015-2019
    Published: 19-Nov-2014        Price: US $2500 Onwards        Pages: 86
    Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. According to the CDC, prominent symptoms of irritable bowel syndrome include severe bloa......
  • Inflammatory Bowel Disease – Pipeline Review, H2 2014
    Published: 18-Nov-2014        Price: US $2000 Onwards        Pages: 350
    Global Markets Direct's, ‘Inflammatory Bowel Disease Pipeline Review, H2 2014', provides an overview of the Inflammatory Bowel Disease's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press re......
  • Global and Chinese Cisapride Industry, 2009-2019 Market Research Report
    Published: 12-Nov-2014        Price: US $2400 Onwards        Pages: 150
    The 'Global and Chinese Cisapride Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Cisapride industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cisapride manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • Ulcerative Colitis – Pipeline Review, H2 2014
    Published: 30-Oct-2014        Price: US $2000 Onwards        Pages: 343
    Global Markets Direct's, ‘Ulcerative Colitis Pipeline Review, H2 2014', provides an overview of the Ulcerative Colitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ......
  • EpiCast Report: Irritable Bowel Syndrome – Epidemiology Forecast to 2023
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 49
    Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a significant negative impact on a patient's quality of life and social functioning. That said, IBS is ......
  • Global and Chinese Linaclotide Industry, 2009-2019 Market Research Report
    Published: 26-Oct-2014        Price: US $2400 Onwards        Pages: 150
    The 'Global and Chinese Linaclotide Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Linaclotide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Linaclotide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, ap......
  • Global and Chinese Esomeprazole Industry, 2009-2019 Market Research Report
    Published: 26-Oct-2014        Price: US $2400 Onwards        Pages: 150
    The 'Global and Chinese Esomeprazole Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Esomeprazole industry with a focus on the Chinese market. The report provides key statistics on the market status of the Esomeprazole manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • Global and Chinese Tegaserod Industry, 2009-2019 Market Research Report
    Published: 26-Oct-2014        Price: US $2400 Onwards        Pages: 150
    The 'Global and Chinese Tegaserod Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Tegaserod industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tegaserod manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs